Natarajan Sethuraman
Technik-/Wissenschafts-/F&E-Leiter bei ENTRADA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Natarajan Sethuraman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 | - |
Karriereverlauf von Natarajan Sethuraman
Ehemalige bekannte Positionen von Natarajan Sethuraman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERCK & CO., INC. | Direktor/Vorstandsmitglied | 01.08.2006 | 01.07.2016 |
| Corporate Officer/Principal | 01.08.2006 | 01.07.2016 | |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - | - |
Ausbildung von Natarajan Sethuraman
| Tamilnadu Agricultural University | Undergraduate Degree |
| Indian Agricultural Research Institute | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Indien | 3 |
| Deutschland | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
- Börse
- Insiders
- Natarajan Sethuraman
- Erfahrung
